Literature DB >> 8042446

Mechanisms of tizanidine action on spasticity.

I Milanov1, D Georgiev.   

Abstract

This investigation estimated the mechanisms of tizanidine action on spasticity using a battery of neurophysiological methods. Thirty patients with old post-stroke spastic hemiparesis took part in the investigation. They were treated with tizanidine-mean daily dose 15.8 +/- 5.6 mg for a mean of 23.3 +/- 4.8 days. A questionnaire for assessment of subjective improvement after treatment used a 5-point scale. For standardization of the neurological examination 5-point scales were used to assess muscle tone, muscle force and tendon reflexes. A battery of neurophysiological methods was used to analyze different mechanisms of spasticity: for alpha motoneuron excitability--the F wave parameters; for presynaptic inhibition--the ratio of H reflex amplitudes before and after vibration of the achilles tendon (Hvibr/Hmax); for common interneuron activity--the flexor reflex parameters. Our results revealed that tizanidine reduces spastically increased muscle tone, but has no influence on muscle force, tendon reflexes, Babinski sign and ankle clonus. Tizanidine is supposed to act by increasing the presynaptic inhibition and decreasing of alpha motoneuron excitability. When spasticity has decreased presynaptic inhibition and increased motoneuron excitability, it is better to treat with tizanidine.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8042446     DOI: 10.1111/j.1600-0404.1994.tb01680.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  9 in total

1.  Short-term effects of thermotherapy for spasticity on tibial nerve F-waves in post-stroke patients.

Authors:  Shuji Matsumoto; Kazumi Kawahira; Seiji Etoh; Satoshi Ikeda; Nobuyuki Tanaka
Journal:  Int J Biometeorol       Date:  2005-12-22       Impact factor: 3.787

2.  Tizanidine-induced hypotension in patients with liver cirrhosis.

Authors:  Kenji Momo; Masato Homma; Makoto Abei; Ichinosuke Hyodo; Yukinao Kohda
Journal:  Eur J Clin Pharmacol       Date:  2008-06       Impact factor: 2.953

3.  Beneficial effects of footbaths in controlling spasticity after stroke.

Authors:  Shuji Matsumoto; Megumi Shimodozono; Seiji Etoh; Yurika Shimozono; Nobuyuki Tanaka; Kazumi Kawahira
Journal:  Int J Biometeorol       Date:  2010-02-17       Impact factor: 3.787

Review 4.  Tizanidine. A review of its pharmacology, clinical efficacy and tolerability in the management of spasticity associated with cerebral and spinal disorders.

Authors:  A J Wagstaff; H M Bryson
Journal:  Drugs       Date:  1997-03       Impact factor: 9.546

Review 5.  Myofascial pain disorders: theory to therapy.

Authors:  Anthony H Wheeler
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 6.  Drugs used to treat spasticity.

Authors:  M Kita; D E Goodkin
Journal:  Drugs       Date:  2000-03       Impact factor: 11.431

7.  Irreversible profound symptomatic bradycardia requiring pacemaker after tizanidine/loxoprofen combination therapy: a case report.

Authors:  Xiaolin Li; Yunpeng Jin
Journal:  J Int Med Res       Date:  2018-03-27       Impact factor: 1.671

8.  Assessing Drug Interaction and Pharmacokinetics of Loxoprofen in Mice Treated with CYP3A Modulators.

Authors:  Sanjita Paudel; Aarajana Shrestha; Piljoung Cho; Riya Shrestha; Younah Kim; Taeho Lee; Ju-Hyun Kim; Tae Cheon Jeong; Eung-Seok Lee; Sangkyu Lee
Journal:  Pharmaceutics       Date:  2019-09-16       Impact factor: 6.321

9.  Pain Management for Dental Medicine in 2021: Opioids, Coronavirus and Beyond.

Authors:  Steven J Scrivani; David A Keith; Ronald J Kulich; Alexandre F DaSilva; R Bruce Donoff; Shruti Handa; Nicole Holland; Mark A Lerman; Jenna L McCauley; Lori Reisner; Cory M Resnick; Christian S Stohler; Alexis Vasciannie; Matthew Fortino; Michael E Schatman
Journal:  J Pain Res       Date:  2021-05-24       Impact factor: 3.133

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.